13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q1 2021. See the latest, Q3 2026 →

Reported value

$12.56B

+16% on the quarter before

Positions

59

27 new, 13 sold out

Top 10

64.8%

of the value

Est. gain

+$1.10B

on stocks held all quarter

Est. return

+12.4%

on those stocks since Q4 2020

Filed

May 14, 2021

On SEC EDGAR ↗

Positions as of Mar 31, 2021, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2020. Striped tiles are options.

Intel12%
Liberty Global Plc11%
35 others9.7%
Ebay Inc.8.9%
Qorvo7.6%
Viasat Inc6.2%
Alphabet4.8%
Willis Towers Watson Plc Ltd4.6%
Micron3.8%Meta3.0%
Pg&E Corp2.9%
Pershing Square Tontine Hldg2.4%
Translate Bio Inc2.4%
International Flavors&Fragra2.3%
Nexstar Media Group Inc2.3%
Liberty Media Corp Del2.3%
Fox Corp2.2%
Ss&C Technologies Hldgs Inc2.1%
Fox Corp1.6%
Liberty Global Plc1.6%
Theravance Biopharma Inc1.4%
Healthpeak Properties Inc1.3%
Colony Cap Inc New1.2%
Liberty Media Corp Del1.2%
Veritiv Corp1.2%

Largest buys

Since Q4 2020, sized at quarter-end prices.

  1. Willis Towers Watson Plc Ltd~$572.2MNew, 0.0% → 4.6% of the portfolio+2,500,000 shares
  2. Alphabet~$437.2MAdded, 1.3% → 4.8% of the portfolio+211,350 shares
  3. Intel~$327.7MAdded, 8.4% → 11.9% of the portfolio+5,119,765 shares
  4. International Flavors&Fragra~$293.2MNew, 0.0% → 2.3% of the portfolio+2,100,000 shares
  5. Qorvo~$143.3MAdded, 6.8% → 7.6% of the portfolio+784,371 shares
  6. Meta~$111.0MAdded, 2.3% → 3.0% of the portfolio+377,000 shares
  7. Nuvation Bio Inc~$82.4MNew, 0.0% → 0.7% of the portfolio+8,623,021 shares
  8. Cullinan Oncology Inc~$71.7MNew, 0.0% → 0.6% of the portfolio+1,835,560 shares
  9. Reinvent Technology Partners~$60.2MNew, 0.0% → 0.5% of the portfolio+6,000,000 shares
  10. Ajax I~$51.3MNew, 0.0% → 0.4% of the portfolio+5,000,000 shares

Largest sells

Since Q4 2020, sized at quarter-end prices.

  1. Ebay Inc.~$783.3MCut, 14.4% → 8.9% of the portfolio−12,790,800 shares
  2. Fox Corp~$526.3MCut, 6.0% → 2.2% of the portfolio−14,576,132 shares
  3. Marathon Pete Corp~$318.1MSold out, 2.9% → 0.0% of the portfolio−7,690,721 shares
  4. Viacomcbs Inc~$175.1MSold out, 1.6% → 0.0% of the portfolio−4,700,000 shares
  5. Ajax I~$62.0MSold out, 0.6% → 0.0% of the portfolio−5,000,000 shares
  6. Redball Acquisition Corp~$53.9MSold out, 0.5% → 0.0% of the portfolio−4,950,000 shares
  7. Vesper Healthcare Acqstn Cor~$44.8MSold out, 0.4% → 0.0% of the portfolio−3,960,000 shares
  8. Avanti Acquisition Corp~$43.4MSold out, 0.4% → 0.0% of the portfolio−4,000,000 shares
  9. Reinvent Technology Partners~$42.9MSold out, 0.4% → 0.0% of the portfolio−3,500,000 shares
  10. Horizon Acquisition Corporat~$37.6MSold out, 0.3% → 0.0% of the portfolio−3,500,000 shares

Holdings

As of Mar 31, 2021; changes in shares since Dec 31, 2020.

Positions, sorted by share of the portfolio
HoldingValue
IntelCOM · shares +28% · price +28.5%11.9%$1.49B+$257.9M
Liberty Global PlcSHS CL C · shares 0% · price +8.0%11.1%$1.39B+$103.1M
Ebay Inc.COM · shares −41% · price +21.9%8.9%$1.12B+$201.4M
QorvoCOM · shares +18% · price +9.9%7.6%$954.5M+$73.0M
Viasat IncCOM · shares 0% · price +47.2%6.2%$783.0M+$251.2M
AlphabetCAP STK CL C · shares +266% · price +18.1%4.8%$601.8M+$25.2M
Willis Towers Watson Plc LtdSHS · shares New4.6%$572.2M—
MicronCOM · shares +3.9% · price +17.3%3.8%$478.4M+$68.0M
MetaCL A · shares +41% · price +7.8%3.0%$382.0M+$19.7M
Pg&E CorpCOM · shares 0% · price −6.0%2.9%$359.0M−$23.0M
Pershing Square Tontine HldgCOM CL A · shares 0% · price −13.4%2.4%$305.1M−$47.1M
Translate Bio IncCOM · shares 0% · price −9.3%2.4%$295.8M−$30.4M
International Flavors&FragraCOM · shares New2.3%$293.2M—
Nexstar Media Group IncCL A · shares 0% · price +28.6%2.3%$292.8M+$65.1M
Liberty Media Corp DelCOM C SIRIUSXM · shares 0% · price +1.4%2.3%$286.0M+$3.9M
Fox CorpCL A COM · shares −66% · price +24.0%2.2%$274.8M+$53.2M
Ss&C Technologies Hldgs IncCOM · shares +15% · price −4.0%2.1%$266.0M−$9.5M
Fox CorpCL B COM · shares 0% · price +20.9%1.6%$198.4M+$34.4M
Liberty Global PlcSHS CL A · shares 0% · price +5.9%1.6%$196.5M+$11.0M
Theravance Biopharma IncCOM · shares 0% · price +14.9%1.4%$178.3M+$23.1M
Healthpeak Properties IncCOM · shares +24% · price +5.0%1.3%$157.7M+$6.0M
Colony Cap Inc NewCL A COM · shares 0% · price +34.7%1.2%$156.9M+$40.4M
Liberty Media Corp DelCOM A SIRIUSXM · shares 0% · price +2.1%1.2%$154.3M+$3.1M
Veritiv CorpCOM · shares 0% · price +104.6%1.2%$151.6M+$77.5M
Advantage Solutions IncCOM CL A · shares 0% · price −10.9%1.1%$143.6M−$17.6M
Total 59 positions100%$12.56B+$1.10B

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2020 to Q1 2021: 31 stocks held throughout, up $1.10B (+12.4%).

  1. Intel+$257.9M+28%
  2. Viasat Inc+$251.2M+47%
  3. Ebay Inc.+$201.4M+22%
  4. Liberty Global Plc+$103.1M+8%
  5. Veritiv Corp+$77.5M+105%
  6. Pg&E Corp−$23.0M−6%
  7. Translate Bio Inc−$30.4M−9%
  8. Atara Biotherapeutics Inc−$44.7M−27%
  9. Pershing Square Tontine Hldg−$47.1M−13%
  10. Verint Sys Inc−$49.7M−32%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free